Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Gemigliptin is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor(KD : 7.25 nM.)
Description | Gemigliptin is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor(KD : 7.25 nM.) |
Targets&IC50 | DPP-4:7.25 nM(KD) |
In vitro | Gemigliptin attenuated vascular calcification and osteogenic trans-differentiation in vascular smooth muscle cells via multiple steps including downregulation of PiT-1 expression and suppression of reactive oxygen species generation, phospho-PI3K/AKT, and the Wnt signaling pathway[1].Gemigliptin treatment attenuated phosphorylated nuclear factor-κB levels, which had been increased in the UUO kidney as well as in TGF-β-treated cultured renal cells[2]. |
Cell Research | Using immunohistochemical and Western blot analysis, Quantitated components of the NLRP3 inflammasome in kidneys with and without gemigliptin treatment, and in vitro in human kidney tubular epithelial human renal proximal tubule cells (HK-2) cells, further analyzed the effect of gemigliptin on transforming growth factor-β (TGF-β)-stimulated production of profibrotic proteins[2]. |
Synonyms | LC15-0444, 吉格列汀酒石酸盐 |
Molecular Weight | 489.37 |
Formula | C18H19F8N5O2 |
CAS No. | 911637-19-9 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 122.5 mg/mL (250.33 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gemigliptin 911637-19-9 蛋白酶体 泛素化 DPP-4 Proteasome Inhibitor LC15-0444 DPP Dipeptidyl Peptidase inhibit inhibitor